Overview

A Pilot Clinical Study Evaluating the Effect of Parathyroid Hormone (PTH) Lowering On Erythropoietin Consumption in Calcitriol-Resistant Patients

Status:
Completed
Trial end date:
2016-04-07
Target enrollment:
Participant gender:
Summary
To evaluate the effect of PTH lowering on erythropoietin consumption in calcitriol-resistant patients with stage 5 chronic kidney disease.
Phase:
Phase 4
Details
Lead Sponsor:
AbbVie (prior sponsor, Abbott)
Treatments:
Calcitriol
Darbepoetin alfa
Epoetin Alfa
Ergocalciferols